Back to News
Market Impact: 0.12
Haisco Enters $1.5 Billion Exclusive License Agreement With Sentivera
Source: Nasdaq
Company FundamentalsPatents & Intellectual PropertyPrivate Markets & Venture
Haisco Pharmaceutical Group (002653.SZ) announced an exclusive licensing agreement with Sentivera, a new US venture backed by Population Health Partners and ARCH Venture Partners. No financial terms or commercial milestones were disclosed in the provided text, making the near-term market impact likely limited.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- Banks, CoreWeave, Nvidia, migration: Australia Briefing
- Ambani’s Jio seeks to raise $3.2B in what could be India’s biggest IPO
- Travis Kelce joined an activist group pushing Six Flags to consider a sale. The ‘Final Destination’-style death of a patron poured gas on the fire
- Huel CEO on Danone Deal and Expansion to US Retail
- Anduril employee tender offer would value the defense tech startup at $90 billion